The role for chemotherapy in the modern management of melanoma.

A Gupta, F Gomes, P Lorigan

Research output: Contribution to journalReview articlepeer-review

Abstract

The treatment of malignant melanoma has changed beyond recognition in the last 7 years. Where previously single agent dacarbazine was often the only treatment used for advanced disease, now there are potentially multiple lines of treatment, based on immunotherapy and targeted treatment options, either as monotherapy or in combination. In this brave new world the question arises, does chemotherapy still have any relevance in the modern management of melanoma? In this review, we summarize the various chemotherapeutic options that have been trialled in melanoma to date, and discuss the role chemotherapy may still play in treating melanoma, potentially in combination with more novel agents, or in certain subtypes of melanoma.
Original languageEnglish
JournalMelanoma Management
DOIs
Publication statusPublished - 19 May 2017

Research Beacons, Institutes and Platforms

  • Manchester Cancer Research Centre

Fingerprint

Dive into the research topics of 'The role for chemotherapy in the modern management of melanoma.'. Together they form a unique fingerprint.

Cite this